 Since patients with AF are a very heterogeneous group and AF burden, comorbidities as well as symptom perception can differ significantly investigators chose to investigate the less diverse group of patients with symptomatic AF that are scheduled for AF ablation. By applying prospective randomization investigators avoid the risk of a significant bias in baseline patient characteristics and comorbidities. 